GIS vs MGNX · P/E 8.2, rev $18.42B vs rev $39.6M
General Mills Inc (GIS) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the GIS and MGNX stock pages for the full models.
Not investment advice.